Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NextCell publishes opinion piece with ISCT

NextCell Pharma AB (”NextCell” or ”Company”) published an opinion piece on particulates in cell and gene therapy products with the International Society for Cell and Gene Therapy’s Process Development, Manufacturing and Analytics Committee last week in the journal Cytotherapy.NextCell Pharma AB is a cell therapy company working in the development and commercialization of the mesenchymal stromal cell therapy product, ProTrans. This product, with its proprietary platform technology, is in clinical development for the treatment of autoimmune conditions, such as type I diabetes and inflammatory

Össur hf: Q3 2022 Results - Conference Call Tuesday 25 October at 9:00 CEST

Announcement no. 58/2022 11 October 2022 Conference call on Tuesday 25 October at 9:00 CEST / 7:00 GMT / 3:00 ET Össur will publish its financial results for Q3 2022 prior to market opening on Tuesday 25 October. That same day at 9:00 CEST, Össur will host a conference call where Sveinn Sölvason, President and CEO, and Gudný Arna Sveinsdóttir, CFO, will present and discuss the results of the quarter. The conference call will be conducted in English. A webcast can be followed on the Össur website: http://www.ossur.com/investors To participate in the conference call, please

Aker Solutions ASA: Invitation to Presentation of Third-Quarter Results for 2022

October 11, 2022 - Aker Solutions will publish its third-quarter results for 2022 on Tuesday, October 25, at 07:00 CEST. A live audiocast will take place the same day at 09:00 CEST.The results will be presented by audiocast. To join the live audiocast, go to https://www.akersolutions.com/audiocast There will be a Q&A session at the end of the presentation. Written questions can be submitted through the audiocast solution or sent in advance totorbjorn.andersen@akersolutions.com After the live presentation there will be an opportunity for the press to do individual interviews.

Integrum is granted patent approval for its OPRA[TM] Implant System from the US Patent and Trade Organization

Mölndal, Sweden, October 11[th], 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company has received a patent approval in the US describing components and design features of the OPRA[TM] Implant System, including elements that were implemented in 2017 and later were granted a PMA approval in late 2020. The patent period extends until 2044.Integrum develops the OPRA[TM ]Implant System, a revolutionary implant technology based on the company’s deep expertise and innovations in osseointegration, that help amputees regain normal mobility and quality

BGaming Celebrates Spooky Season in New Halloween Bonanza

Featuring reels packed with Halloween attributes and symbols, the action takes place on a 6×5 layout, utilising cascading reels to land consecutive wins.The studio is all set for the Halloween celebrations and welcomes players to engage with its spookiest release of the year, Halloween Bonanza . Featuring reels packed with Halloween attributes and symbols, the action takes place on a 6×5 layout, utilising cascading reels to land consecutive wins.  Landing 4+ burning pumpkin scatter symbols unlocks the Free Spins bonus round, awarding a

Gedea Biotech reports results from placebo-controlled clinical trial of pHyph, an antibiotic-free treatment for bacterial vaginosis

· Symptom reduction was seen in 90% of patients and absence of symptoms was noted in 70% of patients · Clinical cure rate was 50,4% in the pHyph group, which is in line with many antibiotic treatments on the market · The rate of recurrence of BV was substantially lower at day 35 with pHyph, 13.9%, compared to the standard treatment, 47.5% and throughout the 4 monthsLund, Sweden, October 11, 2022. Gedea Biotech, an innovative women’s health company today reported top-line results from a clinical study, NEFERTITI, of its lead product, pHyph, a vaginal tablet for topical treatment of

Invitation to AAK’s presentation of the third quarter on October 25

In connection with the release of AAK’s Interim report for the third quarter 2022, we invite you to a press and analyst conference to be held on Tuesday, October 25, 2022, at 10 a.m. CET.The conference will be chaired by Johan Westman, President and CEO, and Tomas Bergendahl, CFO.The presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only.   To follow the conference by phone, please use one of the numbers below, followed by pin code 2174196.   SE: +46 8 505 163 86 UK: +44 20

Kindred Group’s Q3 report 2022 and invitation to conference call

Kindred Group plc will publish its interim report for the third quarter 2022 on Thursday 27 October 2022 at 07.30 (CEST).In connection with this, Kindred Group’s CEO Henrik Tjärnström will host a web presentation in English at 10.00 (CEST) which is webcasted live on https://www.kindredgroup.com/q32022. To access the telephone conference in connection with the presentation, please register at https://conference.financialhearings.com/teleconference/?id=10010042. After registration you will be provided phone numbers and a conference ID to access the conference. Please call in well in

Repurchase of NCC Series B shares in week 40, 2022

During the period October 3 – October 7, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 537,310 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

Invitation to SSAB’s third quarter 2022 results briefing

SSAB invites you to a presentation of the report for the third quarter of 2022 at 9.30am CEST on Tuesday, October 25, 2022. The report will be published at approximately 7.30am CEST on the same date.The report will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Leena Craelius. The press conference will be held in English and live webcast on SSAB’s website www.ssab.com. You can also participate in the briefing by telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 9.30am CEST. Teleconference numbers:

Significant Commercial Order received for Zwipe Pay Platform

OSLO, NORWAY– 11 October 2022 – Zwipe is proud to announce a significant commercial order for its Zwipe Pay platform, which enables smart card manufacturers to deliver biometric payment cards. This order has been placed by one of the world’s largest smart card manufacturers delivering tens of millions of payment cards globally. The order value is approximately USD 225,000 and the shipment is targeted for later Q4 2022, making it the single largest commercial order for a quarter in Zwipe’s history. Most notably this initial order is part of a larger volume that the smart card manufacturer

Bridging big to small dimensions: The new COOL-FIT 2.0 Push System

COOL-FIT 2.0 from GF Piping Systems has already changed how you plan, install and operate cooling applications. The pre-insulated plastic piping system is corrosion- and condensation-free and can be installed in cooling applications in commercial and residential construction, data centers, or process cooling. Thanks to the COOL-FIT 2.0 Push System, it now becomes a complete solution: Additional dimensions cover the last meter between the main pipeline and the HVAC unit, leading to higher energy efficiency and a more reliable operation.HVAC technology is becoming increasingly important. The

INVITATION TO PRESENTATION OF MUNTERS INTERIM REPORT JANUARY-SEPTEMBER 2022

On October 21, at 07.30 CET, Munters will release the interim report for January-September for 2022. Media, investors and analysts are on the same day invited to attend a presentation of the report at 09.00 CET. The President and CEO, Klas Forsström, together with the Group Vice President and CFO, Annette Kumlien will present the report in a webcast with telephone conference. Webcast: Link to webcast: https://ir.financialhearings.com/munters-q3-2022 Conference call: Please, dial in using one of the numbers below and the pin code: SE: +46 8 505 163 86UK: +44 20 319 84884

Eltel’s Nomination Committee composition for the AGM 2023

Pursuant to the instruction for Eltel AB´s Nomination Committee the company shall have a Nomination Committee comprising one representative for each of the four largest shareholders, registered with Euroclear Sweden AB on the last banking day in August the year before the Annual General Meeting (AGM).On 31 August 2022, the four largest shareholders of Eltel AB were Solero Luxco S.á.r.l. (a company controlled by Triton Funds), Wipunen Varainhallinta Oy, the Fourth Swedish National Pension Fund (AP4), and Heikintorppa Oy. All of the shareholders referred to above together represent 48.2% of

Inwido AB’s Nomination Committee for the 2023 Annual General Meeting

Based on the ownership structure as of August 31, 2022 the largest shareholders in Inwido AB (publ) in terms of voting rights were consulted and expressed their desire to participate in the nomination process. The Nomination Committee has been appointed by Swedbank Robur Fund, the fourth AP Fund and the Lannebo Fund. Each has appointed a representative, as detailed below, who, together with Per Bertland, the chairman of the board, constitute Inwido´s Nomination Committee.Members of the Nomination Committee: · Bo Lundgren, Swedbank Robur Fund (Chairman of the Nomination Committee) ·

Invitation – SEB’s results for the third quarter 2022

On Wednesday 26 October, at approximately 07:00 CET, SEB’s results for the third quarter 2022 will be announced. In addition, presentations and the Fact Book will be available at sebgroup.com/ir . You are invited to participate in the following event: Telephone conferenceTime: 09:00 CETJohan Torgeby, SEB’s President and CEO, and Masih Yazdi, CFO, will present the results, followed by a Q&A session with Johan Torgeby, Masih Yazdi and Pawel Wyszynski, Head of Investor Relations. The presentation and Q&A will be conducted in English. To participate in the

IFS announces winners of the 2022 Partner of the Year Awards

Miami, Florida, UNITED STATES, October 11, 2022 – IFS, the global cloud enterprise software company, is today announcing the winners of its Partner of the Year Awards. The annual event recognizes partners’ continued dedication to the IFS Partner Program, commitment to excellence in the service(s) delivered to mutual customers, and expertise in leveraging innovation to extend the capabilities of IFS’s solution. The announcement is taking place this year at the IFS global partner event, IFS Unleashed (Miami Beach Convention Center (MBCC), Miami, Florida, United States, October 10-14, 2022).

BioStock: Chordate introduces migraine treatment in Finland

Chordate Medical recently presented positive results from the German part of a large migraine study showing that K.O.S is an effective and safe treatment for chronic migraine. With these study results, the company chooses to broaden its focus on chronic migraine and introduce the treatment in Finland, as the successful PM007 study also includes Finnish clinics. The company’s CEO Anders Weilandt tells us more in an interview with BioStock.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/chordate-introduces-migraine-treatment-in-finland/ This is a press release

Eficode becomes an official Atlassian Specialized Partner in ITSM

Productized ITSM services enable tighter collaboration between IT operations and software developmentHelsinki, Finland, October 11, 2022 – Eficode  is at the forefront in the Nordics to become an official Atlassian Specialized Partner in ITSM. The ITSM specialization demonstrates Eficode’s deep knowledge, extensive experience, and delivery of consistent, high-quality services to optimize customer satisfaction and outcomes. “Atlassian would like to recognize Eficode for their specialized delivery practice, as they have proven success implementing service

Read original

Wärtsilä’s Interim report January-September 2022 to be published 25 October 2022 at 8.30 a.m. local time

Wärtsilä Corporation, Press release, 11 October 2022 at 10:30 EESTWärtsilä Corporation will publish its interim report for the period January-September 2022 on Tuesday 25 October 2022 at 8.30 a.m. Finnish time. The report will be available in pdf-format on the company website at www.wartsila.com after publishing. A virtual analyst and press conference will be held as a webinar on the same day, Tuesday 25 October 2022, at 10.00 a.m. Finnish time (8.00 a.m. UK time).If you only wish to view the stream, please register at: http://www.mediaserver.fi/live/wartsila. If you plan to view

Spectrumone AB has sold 100% of the shares in Ådata Infosystems AB

Spectrumone AB has sold 100% of the shares in Ådata Infosystems AB (“Ådata”) to Mavshack AB at an enterprise value of SEK 10 million, on a cash-free and debt-free basis and assuming a normalized level of working capital. The purchase price will be settled in cash and a vendor loan with all the shares in Å-data as collateral. Closing took place today. ÅData has been a supplier of its in-house developed business system to more than 10 municipalities in Sweden for many years. The business was started in 1984 and since 2020 has been part of SpectrumOne. The background to Spectrumone choosing

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 207 - 11 OCTOBER 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Pharmacolog expands agreement with Codonics

Pharmacolog and Codonics extend existing agreement to include sales of DrugLog™ and associated services into GCC countries and Jordan.Pharmacolog and Codonics is expanding their strategic agreement to now include Codonics distribution of DrugLog™ into Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, and Jordan. This makes Codonics the exclusive distributor of DrugLog™ in the U.S., Canada, and Middle East and WasteLog™ in the U.S., Mexico, China, and the Middle East. Less than one year ago, Pharmacolog and Codonics expanded their original agreement to include Codonics’

SSAB and POSCO organize a global conference for a greener future

Together for a Green Future! is the slogan for the Hydrogen Iron&Steel Making Forum 2022 in Stockholm this October. It will be hosted by SSAB and South Korean POSCO Group. The focus of the event is to provide a forum where steelmakers can promote collaboration and share advice, ideas and expertise to tackle the global climate change. Registration Steel plays a critical role in developing industries and building communities. One can say our world is built using steel, which is why it is used in every aspect of our

There are no items matching the current filter
There are no more items matching the current filter
Back to top